INTRODUCTION
Pseudomonas aeruginosa is an important opportunistic pathogen that is commonly associated with chronic pulmonary infections in cystic fibrosis (CF) patients, accounting for 90 % of deaths in these individuals (Davies, 2002) . P. aeruginosa strains that initially infect CF patients have phenotypes similar to those found in the environment, which are characterized by having a nonmucoid phenotype. During colonization of the CF lung, P. aeruginosa undergoes a number of morphological changes (Smith et al., 2006) , the most obvious of which is the conversion to a mucoid phenotype that is apparent in up to 90 % of the P. aeruginosa isolated from chronically infected patients (Doggett, 1969; Govan & Deretic, 1996) . Mucoidy is due to the overproduction of the exopolysaccharide alginate.
Alginate production appears to protect P. aeruginosa from environmental stresses such as dehydration, as well as from the host immune system (Parsek & Singh, 2003) . Mucoid strains can adopt a biofilm mode of growth and mucoid biofilms are significantly more resistant to the antibiotic tobramycin than isogenic non-mucoid biofilms (Hentzer et al., 2001) . The overproduction of alginate also enhances adhesion to tracheal epithelial cells (Marty et al., 1998) . In addition, this exopolysaccharide inhibits opsonic phagocytosis (Pier et al., 2001) and promotes resistance to reactive oxygen molecules (Borriello et al., 2004; Simpson et al., 1989) . There is evidence that increased oxidative stress and enhanced lipid peroxidation activity in the CF lung result in the oxidation of membrane phospholipids and low-density lipoprotein (LDL) (Winklhofer-Roob et al., 1995; van der Vliet et al., 1997) . These conditions favour the chronic state of infection in CF patients (Ramsey & Wozniak, 2005) . Apart from an increase in alginate production that accompanies the conversion from the non-mucoid to the mucoid phenotype, there is also a decrease in expression of various virulence factors, including flagella, pili, the lipopolysaccharide O antigen and pyocyanin (Luzar et al., 1985; Hancock et al., 1983; Mahenthiralingam et al., 1994; De Vos et al., 2001 ).
The genome sequence of the prototype P. aeruginosa strain PAO1 has been determined (Stover et al., 2000) . It is estimated that over one-third of the genes in the P. aeruginosa genome encode 'hypothetical' or 'conserved hypothetical' proteins. These proteins are recognized by the presence of an ORF that is predicted to encode a protein of unknown function that is either unique to an organism or present among various species.
The availability of the genome sequence along with microarray technology has allowed the detection of global gene expression changes in P. aeruginosa strains under various conditions (Chugani & Greenberg, 2007; Lizewski et al., 2004; Wolfgang et al., 2004; Firoved et al., 2002; Ochsner et al., 2002) . Several groups have identified differences in gene expression between mucoid and nonmucoid strains of P. aeruginosa (Bragonzi et al., 2005; Lizewski et al., 2004; Firoved & Deretic, 2003) . Others have utilized microarray technology to monitor the expression of genes associated with quorum sensing (QS) (Wagner et al., 2003; Schuster et al., 2003) , interactions with host cells (Frisk et al., 2004; Ichikawa et al., 2000; Firoved et al., 2004) and biofilm formation (Bagge et al., 2004; Whiteley et al., 2001) .
Our laboratory has previously reported a proteomic characterization of two genetically similar but phenotypically distinct strains of P. aeruginosa (Hanna et al., 2000) . These strains were isolated from the sputum of a single CF patient and had phenotypes associated with early (383, non-mucoid) and late (2192, mucoid) stages of disease. We have extended our previous observations to the genomic level using P. aeruginosa GeneChip microarray technology and focused on hypothetical and conserved hypothetical proteins that show differential expression between these two strains. In the present study, we analysed a gene, PA0122, which has been recognized by others as being QSregulated (Wagner et al., 2003; Schuster et al., 2003) . We show that expression of the PA0122 gene and protein is growth phase-dependent and that it is more abundantly expressed in the non-mucoid strain 383 than in the mucoid strain 2192. We also report that PA0122 is a novel oxidized LDL (Ox-LDL) and lysophosphatidylcholine (lysoPC) binding protein in P. aeruginosa.
METHODS
Bacterial strains and growth conditions. Bacterial strains and plasmids used in this study are described in Table 1 . P. aeruginosa strains 383 and 2192 are non-mucoid and mucoid, respectively. They were isolated 2 days apart from the sputum of the same CF patient (Hanna et al., 2000) . Non-mucoid derivatives (nmd) of mucoid strains were isolated from their respective mucoid strains by repeated passage in static Luria-Bertani (LB) broth at room temperature followed by plating on tryptic soy agar (TSA) plates. Escherichia coli DH5a (Invitrogen) cells were used as recipients for plasmid constructs. For selection in E. coli, 50 mg ml 21 kanamycin (Km), 50 mg X-Gal ml 21 and 1 mM IPTG were added as required.
Total RNA isolation and quantitative real-time RT-PCR (qRT-PCR). For RNA isolation, P. aeruginosa strains were grown overnight shaken at 200 r.p.m. in LB broth at 37 uC. Cultures were diluted 1 : 100 in 30 ml fresh LB medium and grown to mid-exponential phase (OD 600 0.5). Bacterial cells were pelleted by centrifugation at 3220 g for 15 min at 4 uC. Total RNA was isolated using the RiboPure Bacterial (RNAwiz) kit (Ambion) and contaminating DNA was removed with the DNA-free kit (Ambion) following the manufacturer's specification.
The expression of the P. aeruginosa PA0122 gene was examined by qRT-PCR. Total RNA was isolated from strain 383 and strain 2192 cultures at different phases of growth, as well as from other mucoid strains and their nmd at OD 600 0.5. qRT-PCR was performed using SYBR Green 1 chemistry in an Applied Biosystems 7900 HT Sequence Detection System. Target sequences were obtained from Affymetrix (https://www.affymetrix.com/analysis/netaffx/). Primers were designed using Primer Express (Applied Biosystems). For PA0122, the following primers were used: forward, 59-ACCCAGGGC-AGCTTCGA-39, and reverse, 59-GGGTCATCCCAGCTGAAGGT-39. Relative abundance was normalized against PA1777 (OprF) using forward primer 59-CAGCTGGACGTGAAGTTCGA-39 and reverse primer 59-GAAGTCAGCCAGGTTCTTGATGT-39.
PA0122 cloning and recombinant protein expression in E. coli.
The PA0122 gene was amplified by PCR using genomic DNA from strain 383 as a template. Genomic DNA was isolated as previously described (Goldberg & Ohman, 1984) . The primers (PA0122-HisF, 59-GTTAACGGAATTCGACATGGCATACGCAG-39; PA0122-HisR, 59-GCTCCAGGTACTCGAGGGAGAAGCGGCCG-39) were designed using the sequence of PA0122 from the P. aeruginosa PAO1 genome (http://www.pseudomonas.com). To facilitate cloning into the pET28b (+) expression vector (Novagen), the PA0122-HisF (forward primer) and PA0122-HisR (reverse primer) were engineered with EcoRI and XhoI restriction sites (indicated by bold type). After PCR amplification, samples were separated by 0.7 % agarose gel electrophoresis and stained with ethidium bromide. The resultant 0.45 kb DNA fragment was excised and purified using the QIAquick Gel Extraction kit (Qiagen) and cloned into the pCR2.1-TOPO vector (Invitrogen), as described by the manufacturer's protocol. TOPOligated product was transferred into DH5a cells, and colonies were selected on LB agar containing Km, X-Gal and IPTG. Plasmids purified using the QIAprep Spin Miniprep kit (Qiagen) were digested with EcoRI and XhoI, and the 0.45 kb fragment was isolated and inserted into pET-28b(+). The resultant construct was transformed into DH5a, then selection for Km-resistant colonies was performed. Plasmids isolated from transformations were designated pET-PA0122-his. The presence of the nucleotides encoding six histidine residues at the 39 end of the gene (his-tag) in pET-PA0122-his was For expression in E. coli, a single colony of NovaBlue (DE3) containing pET-PA0122-his was inoculated into LB broth and grown to OD 600 0.5. Cells were induced with 1 mM IPTG and harvested after reaching OD 600 1.0. After IPTG induction, the total lysate of E. coli containing pET-PA0122-his was separated by SDS-PAGE and blotted onto nitrocellulose membranes. An expressed protein of 16 kDa was detected with Ni-NTA-peroxidase, indicating the presence of the his-tag (data not shown).
The purification of the his-tagged recombinant PA0122 (r-PA0122) protein was carried out under native conditions by gravity-flow using BD TALON immobilized metal affinity chromatography (IMAC) resin, following the manufacturer's specification (BD Biosciences Clontech). The purified r-PA0122 protein was quantified by the method of Bradford (1976) (Bio-Rad) , while the purity of the protein was assessed by using SDS-PAGE gels stained with Coomassie blue R-250 or silver (Chen et al., 1993; Shevchenko et al., 1996) . Purified r-PA0122 protein was used for immunization and binding assays.
Polyclonal r-PA0122 antibody production and characterization.
Polyclonal antibody was raised against r-PA0122 in 6-8 week old BALB/ c mice (Jackson Laboratories). Prior to immunization, blood samples were collected from each animal through the tail vein and separated serum (pre-immune serum) was stored at 220 uC. Primary immunization was carried out with 100 mg r-PA0122 protein emulsified with Freund's complete adjuvant (1 : 1, v/v) and administered subcutaneously. Two subsequent boosters consisting of 50 mg r-PA0122 emulsified in incomplete Freund's adjuvant (1 : 1) were administered at intervals of 21 days. Ten days after the final booster, blood was collected from the tail vein and separated serum was stored at 220 uC. Animal immunizations were conducted with the approval of the Animal Research Committee at the University of Virginia School of Medicine in accordance with Institute of Laboratory Animal Resources Commission on Life Sciences (1996) and other relevant publications.
For some Western blot analyses, pooled anti-r-PA0122 mouse polyclonal antiserum was adsorbed with NovaBlue (DE3) cells containing the pET-28b(+) cloning vector. For this, 4 ml E. coli grown in LB was pelleted and resuspended in 4 ml PBS and sonicated. Cell lysate (1 mg ml 21 ) was mixed with antiserum, diluted 1 : 50 and adsorbed overnight at 4 uC, followed by pelleting at 20 800 g. This step was repeated twice. The resulting supernatant was filtered using a 0.22 mm pore-size syringe filter (Millipore). A final dilution (1 : 2500) of adsorbed antiserum was made in killer filler (KF) reagent (1.8 l 16 PBS with 200 ml 0.1 M NaOH, 10 g casein and 10 g BSA, adjusted to pH 7.4; 0.2 g phenol red and 3.6 g sodium azide were then added).
Total proteins from whole-cell lysate. A 1 ml volume of an overnight culture, or of cultures at different cell densities, was pelleted, resuspended and sonicated with Tris-EDTA buffer (50 mM Tris, pH 8.3, 5 mM EDTA) containing 50 ml of a cocktail of bacterial protease inhibitors (Sigma) and 1 ml benzonase (Sigma; 5000 U ml 21 ). Cell debris was removed by centrifugation at 20 800 g for 10 min. Protein concentrations were determined by Bradford assay.
Analysis of supernatant proteins. Supernatants were collected from cultures grown in LB medium at different cell densities by centrifugation at 3220 g for 15 min, and filtered through 0.22 mm pore-size filters. The supernatant was added to cold acetone (1 : 10) and allowed to stand overnight at 220 uC. Acetone-precipitated proteins were centrifuged at 3220 g for 15 min. Precipitated protein pellets were resuspended in 1.0 ml 50 mM Tris-EDTA (pH 8.3) buffer containing a cocktail of bacterial protease inhibitors and dialysed exhaustively against Tris-EDTA at 4 uC. Protein samples were concentrated to 100 ml using Amicon centrifugation devices (Millipore), followed by protein quantification, and stored at 220 uC.
Subcellular compartment separation. P. aeruginosa 383 and 2192 were grown overnight at 37 uC in LB (200 r.p.m.), subcultured (1 : 100) in 200 ml LB and grown to OD 600 1.5. Bacterial cells were pelleted and various subcellular compartments were isolated as described elsewhere (Hancock & Nikaido, 1978) . In brief, bacterial pellets were resuspended in 15.0 ml ice-cold 10 mM Tris/HCl (pH 8.0) containing 50 ml of a cocktail of protease inhibitors and 5 ml benzonase (346 U ml 21 ). This suspension was disrupted by a French pressure cell press (American Instrument Company) at 18 000 p.s.i. (124 MPa) three times, and further incubated for 30 min at room temperature. The disrupted cell suspension was This study centrifuged at 3220 g for 15 min at 4 uC and the cell debris removed. The clear supernatant suspension was designated whole-cell extract (WEx) and subjected to ultracentrifugation at~100 000 g for 6 h in an SW41Ti rotor (Beckman) at 4 uC. The pellets were classified as total membranes (TMEx) and the supernatant as the cytosolic/ periplasmic fraction; both were stored at 220 uC.
The TMEx were resuspended in 5 ml 20 % (w/w) sucrose in 10 mM Tris/HCl (pH 8.0) containing 1 mM EDTA and 200 mM DTT. Discontinuous eight-step sucrose density gradients were created in 12 ml Ultra-Clear centrifuge tubes (Beckman). Each gradient was layered with 1 ml of 75, 60, 55, 50, 45, 40 and 30 % sucrose. The 5 ml volume of 20 % sucrose that contained the membrane suspension was applied to the top of the sucrose step gradient (Skaar et al., 2002) . The gradient was centrifuged using an SW41Ti rotor at 190 000 g for 46 h at 4 uC. After centrifugation, 1 ml fractions were subsequently collected from the top, and stored at 220 uC. Protein concentrations of each fraction were determined by the Bradford assay. NADH oxidase activity was used as a marker for inner-membrane fractions, while a mouse mAb to the outer-membrane protein OprF (a kind gift of Dr Robert E. Hancock, Department of Microbiology, University of British Columbia, Vancouver, Canada) was used as a marker for the outer membrane (Mutharia & Hancock, 1983) .
Enzyme assay. NADH oxidase activity was determined by spectrophotometer analysis of absorbance decreases at 340 nm (Tielker et al., 2005) . Briefly, 900 ml reaction buffer (50 mM Tris/ HCl, pH 7.5, containing 0.2 mM DTT and 0.12 mM NADH) was added to 100 ml of each fraction. Samples were incubated at 25 uC for 5 min and the absorbance was monitored.
SDS-PAGE and Western blot analysis. For SDS-PAGE analysis, protein samples were mixed with Laemmli buffer (Laemmli, 1970) , boiled for 10 min and separated on 10 % Tris-Tricine SDS-PAGE (Schagger & von Jagow, 1987 ) gels using the Criterion gel system (Bio-Rad). For Western blot analysis, proteins were transferred onto 0.2 mm nitrocellulose membranes (Bio-Rad) at 100 V for 45 min. Membranes were blocked with either 5 % (w/v) fat-free milk in PBS-T [10 mM PBS (pH 7.4) with 0.05 % Tween-20] or KF reagent for 1 h at room temperature.
Blots were probed with either unabsorbed or absorbed anti-r-PA0122 pooled mouse serum diluted in PBS-T or KF, and incubated overnight at 4 uC. Immunodetection was performed with alkaline phosphatase (AP)-conjugated goat anti-mouse IgG (Southern Biotechnology Associates) or peroxidase-conjugated rabbit anti-mouse IgG secondary antibody (Sigma) at a dilution of 1 : 5000 in PBS-T. The blots were washed three times with PBS-T followed by PBS for 5 min each. Finally, reactivity was visualized with chromogenic substrates 5-bromo-4-chloro-3-indolyl phosphate (BCIP)/nitro blue tetrazolium (NBT; Sigma) for alkaline phosphatase or with TMB (3,39,5,59-tetramethylbenzidine and 0.01 % H 2 O 2 ; Kirkegaard & Perry Laboratories) for peroxidase. In some blots, the peroxidase reaction product was visualized using enhanced chemiluminescence (ECL) according to the manufacturer's protocol (Amersham). To locate outer membrane-containing fractions following sucrose gradients, blots were probed with OprF mAb (1 : 2000), followed by peroxidase-conjugated rabbit anti-mouse IgG antibody (Sigma) at a dilution of 1 : 5000 in PBS-T, and developed with ECL.
Binding of r-PA0122 protein to Ox-LDL. Human-plasma-derived LDL was purchased from EMD Biosciences, and the oxidation of LDL was carried out with hypochlorous acid, as described previously (Coleman et al., 2004) . For the binding assay, r-PA0122 and Ox-LDL were used and complex formation was detected using Western blotting, as described elsewhere (Kudo et al., 2001) . In brief, various concentrations (2, 4 and 8 mg) of r-PA0122 protein were incubated with 10 mg Ox-LDL in 50 ml PBS at 37 uC for 5 h. After incubation, the reaction complex was separated by electrophoresis on a 5 % native polyacrylamide gel (Bio-Rad) using the Criterion gel system (Bio-Rad). The proteins were transferred onto 0.2 mm nitrocellulose membranes (as described above), blocked with 5 % (w/v) fat-free milk in PBS-T for 1 h at room temperature, and probed with anti-r-PA0122 antisera (1 : 5000) overnight at 4 uC on a shaker. Immunodetection was carried out using anti-mouse IgG-peroxidase (Sigma) at 1 : 5000 for 1 h at room temperature. Bound complexes and free protein were visualized by using the ECL detection kit (Amersham).
Immobilization of r-PA0122 protein on NTA and CM5 sensor chips. Surface plasmon resonance (SPR) was performed using the BIAcore 3000 system (BIACore) to analyse interactions and make kinetic measurements between r-PA0122 protein with Ox-LDL and lysoPC (lysophosphatidylcholine; 1-hexanoyl-2-hydroxy-sn-glycero-3-phosphocholine), which is a synthetic short carbon chain (C:6), water-soluble lipid (Avanti Polar Lipids). For direct binding, an NTA sensor chip (BIAcore) was used to immobilize r-PA0122 through the C-terminal his-tag of the protein. Attachment of the ligand was performed following the manufacturer's protocol. Initially, the chip was regenerated by injecting buffer containing 0.01 % HEPES, 0.15 M NaCl, 0.35 M EDTA and 0.005 % Surfactant P20, pH 8.3, for 1 min. After washing, the system was pulsed for 1 min in 500 mM NiCl 2 running/eluent buffer (0.01 % HEPES, 0.15 M NaCl, 0.35 M EDTA, 0.005 % Surfactant P20, pH 7.4) to saturate NTA with Ni 2+ ions at the flow rate of 50 ml min 21 . His-tagged r-PA0122 protein (5 mg ml
21
) was dissolved in running buffer, injected by 1 min pulse (flow rate 50 ml min
) and immobilized on the nickel surface.
For the interaction analysis of LDL and Ox-LDL, ligands were dissolved (5 mg ml
) in running/eluent buffer, and injected at the flow rate of 50 ml min 21 at different time points and observed for Ox-LDL binding onto the r-PA0122 surface.
For the kinetic study, r-PA0122 protein was covalently immobilized on a research grade CM5 chip (BIAcore) through amino groups. Briefly, the chip was activated for 5 min with a mixture of Nhydroxysuccinimide (NHS) and N-ethyl-N9-dimethyl-aminopropylcarbodiimide (EDC). The r-PA0122 his-tag protein (100 mg ml 21 ), dissolved in buffer containing 10 mM sodium acetate (pH 4.5), was injected over the activated chip for 5 min at 25 uC. Approximately 0.75 ng r-PA0122-his-tag protein was immobilized per chip and the unbound active sites were deactivated with 1 M ethanolamine-HCl (pH 8.5) for 5 min.
Kinetic analysis of BIAcore sensorgram data. All kinetic data were collected from the BIAcore 3000 system at 25 uC at a flow rate of 50 ml min 21 with running buffer [10 mM HEPES (pH 7.4), 150 mM NaCl, 3 mM ZnCl 2 , 0.005 % Surfactant P20]. To determine the kinetic constants, Ox-LDL and lysoPC were dissolved in running buffer. Ox-LDL or lysoPC was injected to measure association (contact time with the chip was 1 min) and dissociation, which were followed in the same buffer for 5 min. After each kinetic injection, the chip was regenerated with 50 mM NaOH with 1 M NaCl. BIAcore sensorgrams were used according to a 1 : 1 Langmuir binding model, and the BIAevaluation 4.1 software package was applied to calculate kinetic constants.
RESULTS

Gene expression differences between P. aeruginosa 383 and 2192
To identify global gene expression differences between P. aeruginosa strains 383 and 2192, a P. aeruginosa GeneChip microarray analysis was performed. At mid-exponential phase (OD 600 0.5), unique gene expression patterns were observed between these two strains, with 3.4 % of the transcripts (188/5570) expressed differentially. Of the 188 significantly varied (.1.8-fold) genes, 115 were upregulated in 383 while 73 were upregulated in 2192 (see Supplementary Table S1 ). These differentially expressed genes were further separated into their functional classes (see Supplementary Fig. S1a, b) . Among these differentially regulated transcripts, 63.5 % (73/115) in 383 and 58 % (42/ 73) in 2192 were annotated as encoding 'hypothetical' or 'conserved hypothetical' proteins. Of the 115 genes that were upregulated in 383, 12 transcripts had been previously recognized as QS-activated genes (Wolfgang et al., 2004; Schuster et al., 2003) (see Supplementary Table S2) . Three of these genes have annotated ORFs that encode 'hypothetical' or 'conserved hypothetical' proteins. Among these transcripts, we selected PA0122, a 'conserved hypothetical' gene, for further analysis, since it exhibited an 8.02-fold increase in expression in 383 compared to 2192, and had limited homology to previously described proteins.
qRT-PCR for the PA0122 gene
The relative gene expression of PA0122 in 383 and 2192 was confirmed by qRT-PCR, which revealed that expression was~8.8-fold higher in 383 than in 2192 (Fig. 1a) . PA0122 gene expression was followed during growth in strains 383 and 2192. In 383, the highest level of PA0122 gene expression was observed at early stationary phase (OD 600 1.5), and was sixfold higher than that at midexponential phase (OD 600 0.5); the expression of PA0122 decreased at OD 600 2.3. The pattern was similar for 2192, but there was comparatively less PA0122 gene expression than in 383 (Fig. 1b) . These results suggest that PA0122 is regulated by growth phase in both 383 and 2192.
Additional analyses were carried out on nmd of the mucoid strains 2192, FRD1 and 8830 during mid-exponential growth at OD 600 0.5. Strains 2192 nmd , FRD1 nmd and 8830 nmd exhibited 4.3, 1.5 and 4.8-fold increases in relative expression compared to their mucoid parental strains, respectively (Fig. 1a) . These results indicate that PA0122 is expressed at greater levels in these isogenic non-mucoid strains than in the parental mucoid strains. However, different pairs showed different levels of expression.
Analysis of the PA0122 gene product
The PA0122 gene is 411 bp long and is predicted to encode a 136 aa protein with a theoretical molecular mass of 14.58 kDa and a pI of 4.65. PA0122 had limited homology with known proteins from the protein database, but contained a motif analogous to fungal proteins classified in the aegerolysin family of proteins (see Supplementary  Fig. S2 ). PA0122 had 42.52 % identity and 53.54 % similarity (E-value 2e 223 ) with the Asp-haemolysin protein 
212
) to two haemolysin-like proteins from Clostridium bifermentans (CAA71483 and CAA71484). Other similar fungal proteins were Aa-Pri1 from Agrocybe aegerita (AAC02265) with 37.8 % identity and 50.7 % similarity (E-value 5e 215 ), PriA from Pleurotus ostreatus (AAL57035) with 34.0 % identity and 51.5 % similarity (E-value 1e
213
), and a hypothetical protein from Neurospora crassa (XP_32273) with 31.8 % identity and 46.6 % similarity (E-value 6e
212
).
Recognition of native PA0122 protein in P. aeruginosa
Antibodies to r-PA0122 were raised in mice and used to detect native PA0122 from P. aeruginosa. Western analysis of total protein extracts from overnight cultures of 383 and 2192 revealed an immunoreactive band at 16 kDa, a size consistent with the inferred molecular mass of PA0122 (Fig. 2a) . This protein was more abundant in strain 383 than in strain 2192. These results suggest that the PA0122 ORF encodes a protein in P. aeruginosa, and support the microarray and qRT-PCR analyses that indicate that its expression is greater in 383 than in 2192.
To determine the growth-dependent expression of PA0122 protein, strain 383 was harvested at specific cell densities and analysed by Western blotting using anti-r-PA0122 antibodies. A protein band at~16 kDa was observed at OD 600 1.6 and showed a decreased intensity at OD 600 2.0 (Fig. 2b) . A similar pattern of growth phase-dependent expression was seen in strain 2192, but the protein expression level was much lower (data not shown). An immunoreactive protein of the same molecular mass was detected in acetone-precipitated extracts from the supernatant of 383 (Fig. 2c) . In the supernatant fraction, the expression of this protein was apparent at OD 600 1.0, but showed greatest expression at OD 600 1.6 and no expression at OD 600 2.0. In addition, a second immunoreactive band was evident at OD 600 1.6 in both the cellular and supernatant fractions as detected by Western blotting, which may suggest proteolytic degradation of the PA0122 protein.
Subcellular localization of PA0122
To determine the subcellular location of PA0122, P. aeruginosa strains 383 and 2192 were disrupted by French press. A 16 kDa immunoreactive band was detected by Western blotting of whole-cell extracts, cytoplasmic extracts and total membrane extracts of P. aeruginosa strain 383 (Fig. 3) . After further separation of the PA0122 protein by discontinuous (20-75 %) sucrose density gradient, each fraction was analysed for NADH oxidase activity as a marker for the inner membrane (Tielker et al., 2005) , while the presence of OprF was used as a marker for the outer membrane. We observed a prominent immunoreactive band in fractions 6 and 7, while a faint band was seen in other fractions of strain 383 (Fig. 4a) . The outermembrane protein OprF was detected in fractions 9-12, while NADH oxidase activity was confined to fractions 4-6 (Fig. 4b, c) . The band corresponding to PA0122 was absent in the total membrane fractions from 2192, while a band of reduced intensity was detected in 2192 whole-cell and cytoplasmic extracts (Fig. 3) . PA0122 was not detected in sucrose gradients of membrane fractions from strain 2192 (data not shown). Thus, PA0122 is present in the cytoplasm of 383, and also associated with the inner and, to a lesser extent, the outer membrane. In strain 2192, PA0122 is only detected in the cytoplasm.
Binding of r-PA0122 to Ox-LDL
Others have shown that recombinant Asp-haemolysin (rAsp-haemolysin) from A. fumigatus, when expressed in E. coli, is able to bind with Ox-LDL (Kudo et al., 1999, 2002) . Fig. 2 . Western blot analysis using antiserum raised against r-PA0122. (a) Immunoreactivity of native protein from P. aeruginosa 383 and 2192 was detected using mouse-raised polyclonal antibody. Approximately 1 mg r-PA0122 protein and 5 mg 383 and 2192 total proteins were separated on 10 % Tris-Tricine SDS-PAGE gels using the Criterion gel system. Following electrophoresis, proteins were transferred to nitrocellulose and probed with anti-r-PA0122 mouse polyclonal antibody at 1 : 2000. (b, c) Western analysis showing immunoreactivity of the native PA0122 protein obtained from cellular and supernatant fractions from P. aeruginosa strain 383. The samples for immunoblot analysis were collected at different phases of growth corresponding to various OD 600 . Approximately 75 mg cellular extract (b) and 2 mg acetone-precipitated total proteins from the supernatant fraction (c) were separated on 10 % Tris-Tricine by SDS-PAGE using the Criterion gel system. Following electrophoresis, proteins were transferred to nitrocellulose and probed with pooled anti-r-PA0122 mouse antibody at 1 : 10 000.
To determine whether r-PA0122 exhibits similar binding properties, we monitored the binding of different concentrations of r-PA0122 to Ox-LDL at 37 u C under nondenaturing conditions. The formation of r-PA0122-Ox-LDL complexes was detected by Western blot analysis using anti-r-PA0122 antisera as a probe. In this assay, free r-PA0122 protein was detected as a faster-migrating band, while the reactivity of complex formation was concentration-dependent (Fig. 5) ; no binding was seen to LDL. These results indicate that r-PA0122 is able to bind to Ox-LDL, but not to LDL.
Kinetic study of the interaction of r-PA0122 with Ox-LDL, and with lysoPC SPR was used to determine the specific binding and the interaction affinity between r-PA0122 and Ox-LDL. For this experiment, r-PA0122 was bound to a Ni-NTA sensor chip via its his-tag, followed by application of LDL or Ox-LDL at a concentration of 5 mg ml 21 (Fig. 6a) . Binding of r-PA0122 to LDL was not detected (Fig. 6b) , while binding of r-PA0122 to Ox-LDL was observed (Fig. 6c) .
In addition to binding Ox-LDL, it has been found that rAsp-haemolysin binds to lysoPC . To determine the kinetics of binding of Ox-LDL or lysoPC to r-PA0122, the association (K a ) and dissociation (K d ) rates were measured, and the dissociation constant (K D ) was calculated by SPR. Fig. 6(d) shows sensorgrams for Ox-LDL. Ox-LDL had a K D of 1.36610 29 M to r-PA0122. The possible binding subcomponent of Ox-LDL was determined by using water-soluble synthetic short-chain (C:6) lysoPC. Fig. 6 (e) depicts the sensorgrams for lysoPC with a K D of 2.94610 25 M. These calculated values indicate that lysoPC is a bioactive subcomponent of Ox-LDL that associates at a rate similar to that of Ox-LDL, but dissociates more slowly from r-PA0122.
DISCUSSION
In this study we identified PA0122 as an Ox-LDL binding protein of P. aeruginosa. We recognized PA0122 from a P. aeruginosa GeneChip microarray analysis that compared two genetically similar but phenotypically distinct strains of P. aeruginosa, 383 (non-mucoid) and 2192 (mucoid), isolated from the sputum of an individual with CF. Our long-term goal is to determine the major differences in virulence factor expression patterns between strains 383 and 2192 and to establish the role of these factors in pathogenesis during CF infections.
In our microarray analysis, we found 115 genes that were differentially regulated between 383 and 2192 that were classified as encoding 'hypothetical' or 'conserved hypothetical' proteins. Twelve of the 73 genes that were upregulated in strain 383 have been reported elsewhere as being QS-regulated (Wolfgang et al., 2004; Schuster et al., 2003) (Supplementary Table S2 ); three of these were annotated as encoding 'hypothetical' or 'conserved hypothetical' proteins. In P. aeruginosa, QS regulation plays an important role in the production of virulence factors, the development of biofilms and immune modulation during chronic lung infection (Venturi, 2006; Schuster & Greenberg, 2006; Wagner et al., 2006) . In addition, QS also controls the expression of exoproducts such as proteases, exotoxin A, rhamnolipids and pyocyanin (Kong et al., 2005) . Other investigators have identified a number of genes that are regulated by the las and/or rhl QS systems (Venturi, 2006) . The acyl-homoserine lactone (AHL)-dependent transcriptome has been revealed using microarray analysis (Wagner et al., 2003; Schuster et al., 2003) . These studies have shown that approximately 20 % of genes can be identified as being QS-regulated in P. aeruginosa strain PAO1. PA0122 has been recognized as being QS-regulated (Schuster & Greenberg, 2006) , and shown to contain a las box upstream of the ORF Wagner et al., 2003) . PA0122 is upregulated in the stationary phase of planktonic growth and in developed (or confluent) biofilms (Waite et al., 2006) .
In this study, we selected PA0122 for further investigation based on its recognition as being QS-regulated, its differential expression pattern in 383 vs 2192 and its limited homology with previously described proteins. Using qRT-PCR, we recapitulated the growth phase-dependent pattern of PA0122 transcription levels in the non-mucoid strain 383 and the mucoid strain 2192. Immunoblot analysis showed that PA0122 protein expression is also regulated in a growth phase-dependent manner with the peak of protein expression found at OD 600 1.6. Cell fractionation of strain 383 showed that PA0122 protein was detectable in the culture supernatant, where it reached a maximum at OD 600 1.6. However, at OD 600 2.0, PA0122 protein levels were reduced in the cell extracts and absent in the supernatant (Fig. 2b) . The reduction in the protein level at OD 600 2.0 could be due to proteolysis of this protein.
We showed that non-mucoid revertants of three mucoid strains had increased PA0122 gene expression when compared to the mucoid parental strains. In addition, cell fractionation studies in 383 and 2192 revealed differences in the localization of PA0122. In 383, PA0122 was present in the cytoplasmic and membrane fractions, while this protein was only observed in the cytoplasmic fraction of 2192. PA0122 was not detected in crude membrane fractions of strain 2192, even when five times the amount of protein (100 mg) was loaded per lane (data not shown). The mechanism for the differential expression and localization of PA0122 in these strains is currently under investigation.
It should be noted that prior to this work, PA0122 was only recognized as an ORF putatively encoding a conserved hypothetical protein. Our Western blot analysis confirmed that the gene encodes a protein product that is associated with the cytoplasm, the inner membrane and supernatant fraction of strain 383. To our knowledge, this is the first report of a P. aeruginosa protein interacting with Ox-LDL or lysoPC. Previously, P. aeruginosa has been reported to bind to two types of phospholipids, phosphatidyl inositol (PI) and phosphatidylserine (PS), located on the plasma membrane of corneal epithelium (Panjwani et al., 1996) . The authors suggest that association of P. aeruginosa with PI or PS on the surface of host cells could trigger signalling events that might increase the expression of bacterial adhesion and virulence factors. Another study showed that the lysophospholipid 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate (also called monopalmitoylphosphatidic acid) inhibits expression of several secreted virulence factors, including alginate, pyoverdin, elastase and LasA from P. aeruginosa PAO1 (Laux et al., 2002) . None of these studies has reported a receptor for oxidized phospholipid (Ox-PL) binding to P. aeruginosa proteins.
A possible role for PA0122 during infection is suggested from studies of the homologous haemolytic proteins called aegerolysins (Marchler-Bauer & Bryant, 2004) , and in particular Asp-haemolysin, which is a haemolytic toxin Different concentrations of r-PA0122 and Ox-LDL were incubated at 37 6C for 5 h in 50 ml PBS (pH 7.4). Lanes: 1, LDL (10 mg) alone (without protein); 2, LDL (10 mg)+4 mg r-PA0122; 3, Ox-LDL (10 mg); 4, 5 and 6, Ox-LDL (10 mg)+2, 4 and 8 mg r-PA0122, respectively; 7, 8 and 9, r-PA0122 (2, 4 and 8 mg, respectively). The resulting complexes were analysed by Western blotting using anti-r-PA0122 antibody.
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produced by A. fumigatus (Ebina et al., 1985) . The toxic effect of Asp-haemolysin has been demonstrated on various cell types, including macrophages, endothelial cells and red blood cells from humans, rabbits and sheep (Kumagai et al., , 2005 Fukuchi et al., 1998) . It has also been noted that recombinant Asp-haemolysin specifically binds to Ox-LDL and recognizes lysoPC (Kumagai et al., 2006; Kudo et al., 1999 Kudo et al., , 2002 ), but does not exhibit haemolytic activity . Similarly, r-PA0122 did not exhibit haemolytic activity (data not shown). Using SPR, a high binding affinity (1.36610 29 M) was obtained for r-PA0122 and Ox-LDL. A similar binding affinity (1.2610 29 M) has been reported for r-Asphaemolysin and Ox-LDL (Kudo et al., 2001) . In addition, a lower binding affinity (2.94610 25 M) was obtained for r-PA0122 and synthetic C:6-lysoPC. The molecular masses of aegerolysin proteins are reported to be between~14 and 17 kDa, with pIs between 4.0 and 5.0 (Berne et al., 2002) . These characteristics are similar to those we observed for PA0122. Thus, our findings are in agreement with earlier studies reporting the function of r-Asp-haemolysin.
In conclusion, PA0122 is a novel Ox-LDL/lysoPC-binding protein identified in P. aeruginosa. It is more abundant in the non-mucoid strain 383 and localized to different compartments, including the cell membrane and culture supernatant, suggesting that it might interact with Ox-PL in vivo. The role of PA0122 in P. aeruginosa pathogenesis is currently under investigation.
